Skip to main content
OpenTrials
Completed

NCT Number: NCT03830567

Pharmacists Expand Access to Reproductive heaLthcare

Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception

Age range

18 year–51 year

Sex eligibility

Female

Study type

Observational

Primary location

Oregon Health & Science University

Portland, Oregon, 97239, United States

About this study

Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill (HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a medical prescription. Women over 18 years of age can either initiate or continue HCs with a pharmacist, and women under 18 can continue a prescription.

This prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and incident pregnancy rates between women receiving hormonal contraception from a pharmacist versus other prescriber. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women presenting to initiate hormonal contraception at a study pharmacy

Exclusion criteria

  • Pregnancy
  • Contraindications to hormonal contraception
  • Under 18 years of age
  • Unable or unwilling to consent

Treatment and study plan

Pharmacist prescription

Other

Pharmacist prescribed hormonal contraception (initiation or continuation).

Clinician prescription

Other

Clinician prescribed hormonal contraception (initiation or continuation).

Primary outcomes

  1. Contraceptive continuation rates

    Time frame: 12 months

    Percentage of contraceptive continuation assessed through survey at 12 months among women who present for contraception in pharmacies.

Sponsors and collaborators

Lead sponsor

Oregon Health and Science University

Other

Collaborators

  • Laura and John Arnold Foundation

Registry information

Official study title

Pharmacists Expand Access to Reproductive Healthcare: Reducing Unintended Pregnancy Through Pharmacist Prescription of Contraception

Acronym: PEARL

Important dates

Study start
2019
Primary completion
2021
Study completion
2022
First posted
Feb 5, 2019
Registry last updated
Apr 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.